| Статус: | Unknown status |
| Фаза: | Phase 2 |
| Начало: | 22 октября 2020 г. |
| Окончание: | 30 апреля 2021 г. |
| Описание: | The purpose of this study: to assess the safety, tolerability and immunogenicity of the drug "Gam-COVID-Vac", a solution for intramuscular injection, at various times after vaccination in volunteers over 60 years of age |
| смотреть на ClinicalTrials.gov |
| Статус: | Unknown status |
| Фаза: | Phase 2/Phase 3 |
| Начало: | 23 апреля 2020 г. |
| Окончание: | 1 июля 2020 г. |
| Описание: | The study is Phase II/III and consists of pilot and pivotal stages. The objective of the pilot stage is to conduct a preliminary assessment of the efficacy and safety of Favipiravir, and to select the optimal dosing regimen to study during the pivotal stage. The objective of the pivotal stage is to assess the efficacy and safety of Favipiravir compared with the Standard of care (SOC) in hospitalized patients with moderate to severe COVID-19 pneumonia. |
| смотреть на ClinicalTrials.gov |